Microdose Therapytm has 75% Efficacy in the Treatment of Rheumatoid Arthritis

• 

Virgil Stenberg and Helen Stenberg

(PRWEB) March 10, 2013

Virgil Stenberg’s Microdose Therapy tm is more effective in the treatment of rheumatoid arthritis than the most popularly known medications.

Stenberg is the medical director of The Helen Foundation in Mesa, Arizona. He has been researching and studying the effects of cortisone for over 40 years. His studies and medical data prove that his system of self administering cortisol is the most effective treatment of rheumatoid arthritis to date.

The table below is from clinical trial data published in medical journals. Listed is the patient judgment of symptom reduction, also known as, patient global assessment. Rheumatoid arthritis is measured by a variety of parameters such as laboratory measurements, physician global assessment, number of tender joints, the number of swollen joints and patient global assessment.

Rheumatoid arthritis treatment efficacies

Treatment         Administration                                              Efficacy a
Microdose Therapytm    Self-administration                         75%
Adalimumab        Varied dosage and administration frequency        41-61%
Etanercept        Varied dosage and administration frequency         8-51%
Infliximab        Varied dosage and administration frequency        23-47%
Abatacept        Varied dosage and administration frequency        29-44%

Microdose Therapytm is a trade name of the Helen Foundation for patient self-administration of hormone hydrocortisone, a therapy designed and implemented by the Helen Foundation of Mesa, Arizona.

Adlimumab has the trade name Humira and is manufactured by Abbott Laboratories, Abbott Park, IL.

Etanercept has the trade name Enbrel and is manufactured by Immunex Corporation, Thousand Oaks, CA 91320

Infliximab has the trade name Remicade and is manufactured by Janssen Biotech, Inc., a division of Johnson and Johnson, Johnson and Johnson Plaza, New Brunswick, NJ 089933.

Abatacept has the trade name Orencia and is manufactured by Bristol-Meyers Squibb, 345 Park Avenue, New York, NY 10154.

Dr. Stenberg is the author of “Arthritis: The Simple Solution” and “Fibromyalgia Solved.” He is Editor of Proceedings of the North Dakota Academy of Sciences    

President, North Dakota Academy of Sciences

President, Red River Valley Chapter, American Chemical Society

President of the Board, Listen and Drop In Center, for the mentally challenged

International Advisory Board, Interscience World Conference on Inflammation, Geneva

Invited lectures: Australia, Canada, France, India, Japan, Mexico, and Switzerland.

PDF Print